-transparent.png){kind=logo}
Sixty-seven patients entered a double-blind, controlled trial to evaluate the efficacy of propylthiouracil treatment in severe alcoholic hepatitis. Twenty-three percent (7 of 31) given propylthiouracil and 19% (7 of 36) given placebo died during the 6-wk study. Propylthiouracil treatment did not reduce the frequency and incidence of complications in alcoholic hepatitis, but induced hypothyroidism in 4 patients. Treatment produced no beneficial effect on any of the hepatic biochemical tests. We were unable to show any beneficial effect of propylthiouracil treatment on morbidity and mortality in patients with severe acute alcoholic hepatitis.
Related Publications
P Hallé, and
P Paré, and
E Kaptein, and
G Kanel, and
A G Redeker, and
T B Reynolds
March 1980,
Gastroenterology,
P Hallé, and
P Paré, and
E Kaptein, and
G Kanel, and
A G Redeker, and
T B Reynolds
December 2000,
Gastroenterology,
P Hallé, and
P Paré, and
E Kaptein, and
G Kanel, and
A G Redeker, and
T B Reynolds
May 2004,
Hepatology (Baltimore, Md.),
P Hallé, and
P Paré, and
E Kaptein, and
G Kanel, and
A G Redeker, and
T B Reynolds
June 1971,
The New England journal of medicine,
P Hallé, and
P Paré, and
E Kaptein, and
G Kanel, and
A G Redeker, and
T B Reynolds
January 1982,
Gut,
P Hallé, and
P Paré, and
E Kaptein, and
G Kanel, and
A G Redeker, and
T B Reynolds
January 1988,
Neuropsychobiology,
P Hallé, and
P Paré, and
E Kaptein, and
G Kanel, and
A G Redeker, and
T B Reynolds
February 1998,
Journal of hepatology,
P Hallé, and
P Paré, and
E Kaptein, and
G Kanel, and
A G Redeker, and
T B Reynolds
January 2021,
Indian journal of pharmacology,
P Hallé, and
P Paré, and
E Kaptein, and
G Kanel, and
A G Redeker, and
T B Reynolds
June 1989,
Gastroenterologia Japonica,
P Hallé, and
P Paré, and
E Kaptein, and
G Kanel, and
A G Redeker, and
T B Reynolds
April 2004,
Gastroenterology,
